Prescription drug · ANDA
Metyrosine NDC 75907-166
Metyrosine 250 mg/1 · Capsule · Oral · Dr. Reddy's Laboratories Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 75907-166-01 | 75907016601 | 100 CAPSULE in 1 BOTTLE (75907-166-01)Marketed from May 30, 2025 | |
| 75907-166-30 | 75907016630 | 30 CAPSULE in 1 BOTTLE (75907-166-30)Marketed from May 30, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metyrosine
- Generic name (nonproprietary)
- metyrosine
- Active ingredients
- Metyrosine — 250 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218620
- Marketing start
- Listing expires
- Other FDA classes
- Catecholamine Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 75907-166_cd87ec4e-09e2-40d7-831b-0b2e5205dafaSPL ID cd87ec4e-09e2-40d7-831b-0b2e5205dafaSPL set ID 1b7897b4-7681-4b99-8883-d5dc33f86c01RxCUI 197980UNII DOQ0J0TPF7UPC 0375907166303
- Pharmacologic class
- Catecholamine Synthesis Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N475907016601followed by a unit qualifier and the quantityPackage 75907-0166-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Metyrosine capsules are indicated in the treatment of patients with pheochromocytoma for: Preoperative preparation of patients for surgery Management of patients when surgery is contraindicated Chronic treatment of patients with malignant pheochromocytoma Metyrosine capsules are not recommended for the control of essential hypertension.
Excerpt only. Read the full label for complete information.